A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

BACKGROUND: Iron deficiency (ID) is common in patients with chronic kidney disease (CKD). Intravenous (IV) iron in heart failure leads to improvement in exercise capacity and improvement in quality-of-life measurements; however, data in patients with CKD are lacking. METHODS: The Iron and the Heart...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, S., Allgar, V., Lamplugh, A., Macdougall, I., Kalra, P. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010943/
https://www.ncbi.nlm.nih.gov/pubmed/33784968
http://dx.doi.org/10.1186/s12882-021-02308-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010943/
https://www.ncbi.nlm.nih.gov/pubmed/33784968
http://dx.doi.org/10.1186/s12882-021-02308-y

Ejemplares similares